Literature DB >> 27984680

Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia.

Paula Garcia-Esparcia1, Anusha Koneti1, M Cruz Rodríguez-Oroz2,3,4,5, Belen Gago4,5, José Antonio Del Rio5,6,7, Isidro Ferrer1,5,7,8.   

Abstract

Altered mitochondrial function is characteristic in the substantia nigra in Parkinson's disease (PD). Information about mitochondria in other brain regions such as the cerebral cortex is conflicting mainly because most studies have not contemplated the possibility of variable involvement depending on the region, stage of disease progression and clinical symptoms such as the presence or absence of dementia. RT-qPCR of 18 nuclear mRNAs encoding subunits of mitochondrial complexes and 12 mRNAs encoding energy metabolism-related enzymes; western blotting of mitochondrial proteins; and analysis of enzymatic activities of complexes I, II, II, IV and V of the respiratory chain were assessed in frontal cortex area 8 and the angular gyrus of middle-aged individuals (MA), and those with incidental PD (iPD), long-lasting PD with parkinsonism without dementia (PD) and long-lasting PD with dementia (PDD). Up-regulation of several genes was found in frontal cortex area 8 in PD when compared with MA and in the angular gyrus in iPD when compared with MA. Marked down-regulation of genes encoding mitochondrial subunits and energy metabolism-related enzymes occurs in frontal cortex but only of genes coding for energy metabolism-related enzymes in the angular gyrus in PDD. Significant decrease in the protein expression levels of several mitochondrial subunits encoded by these genes occurs in frontal cortex area 8 and angular gyrus in PDD. Moreover, expression of MT-ND1 which is encoded by mitochondrial DNA is also reduced in PDD. Reduced enzymatic activity of complex III in frontal cortex area 8 and angular gyrus is observed in PD, but dramatic reduction in the activity of complexes I, II, II and IV in both regions characterizes PDD. Dementia in the context of PD is linked to region-specific deregulation of genomic genes encoding subunits of mitochondrial complexes and to marked reduction in the activity of mitochondrial complexes I, II, III and IV.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  PDD; Parkinson disease; cerebral cortex; dementia; energy metabolism; incidental PD; mitochondria; oxidative phosphorylation; respiratory chain

Mesh:

Substances:

Year:  2017        PMID: 27984680     DOI: 10.1111/bpa.12474

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  9 in total

Review 1.  Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-20       Impact factor: 3.850

2.  Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.

Authors:  Paula Garcia-Esparcia; Irene López-González; Oriol Grau-Rivera; María Francisca García-Garrido; Anusha Konetti; Franc Llorens; Saima Zafar; Margarita Carmona; José Antonio Del Rio; Inga Zerr; Ellen Gelpi; Isidro Ferrer
Journal:  Front Neurol       Date:  2017-03-13       Impact factor: 4.003

3.  Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson's disease.

Authors:  Sandrine C Foti; Iain Hargreaves; Stephanie Carrington; Aoife P Kiely; Henry Houlden; Janice L Holton
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

4.  Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates.

Authors:  Leonardo Acuña; Sabah Hamadat; Natalia S Corbalán; Florencia González-Lizárraga; Mauricio Dos-Santos-Pereira; Jérémy Rocca; Julia Sepúlveda Díaz; Elaine Del-Bel; Dulce Papy-García; Rosana N Chehín; Patrick P Michel; Rita Raisman-Vozari
Journal:  Cells       Date:  2019-07-25       Impact factor: 6.600

5.  Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Authors:  Alba Pesini; Eldris Iglesias; M Pilar Bayona-Bafaluy; Nuria Garrido-Pérez; Patricia Meade; Paula Gaudó; Irene Jiménez-Salvador; Pol Andrés-Benito; Julio Montoya; Isidro Ferrer; Pedro Pesini; Eduardo Ruiz-Pesini
Journal:  Aging (Albany NY)       Date:  2019-09-27       Impact factor: 5.682

6.  An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank.

Authors:  Stephen M Smith; Gwenaëlle Douaud; Winfield Chen; Taylor Hanayik; Fidel Alfaro-Almagro; Kevin Sharp; Lloyd T Elliott
Journal:  Nat Neurosci       Date:  2021-04-19       Impact factor: 24.884

7.  Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's.

Authors:  Christina E Toomey; Wendy E Heywood; Kevin Mills; Sonia Gandhi; James R Evans; Joanne Lachica; Sarah N Pressey; Sandrine C Foti; Mesfer Al Shahrani; Karishma D'Sa; Iain P Hargreaves; Simon Heales; Michael Orford; Claire Troakes; Johannes Attems; Ellen Gelpi; Miklos Palkovits; Tammaryn Lashley; Steve M Gentleman; Tamas Revesz
Journal:  Acta Neuropathol Commun       Date:  2022-09-08       Impact factor: 7.578

Review 8.  Parkin, an E3 Ubiquitin Ligase, Plays an Essential Role in Mitochondrial Quality Control in Parkinson's Disease.

Authors:  Xiao-Le Wang; Si-Tong Feng; Zhen-Zhen Wang; Yu-He Yuan; Nai-Hong Chen; Yi Zhang
Journal:  Cell Mol Neurobiol       Date:  2020-07-04       Impact factor: 5.046

9.  RNA-sequencing of peripheral blood circular RNAs in Parkinson disease.

Authors:  Fancong Kong; Zhanyun Lv; Lifang Wang; Kui Zhang; Ying Cai; Qingqing Ding; Zuzhen Sun; Hefu Zhen; Fengjuan Jiao; Qianqian Ma; Chao Nie; Yan Yang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.